- Report
- January 2025
- 175 Pages
Global
From €4141EUR$4,490USD£3,512GBP
- Report
- January 2024
- 250 Pages
Global
From €7333EUR$7,950USD£6,219GBP
Veletri is a cardiovascular drug used to treat pulmonary arterial hypertension (PAH). It is a type of prostacyclin, a naturally occurring hormone that helps regulate blood pressure in the lungs. Veletri is administered intravenously and works by relaxing the blood vessels in the lungs, allowing for improved blood flow and oxygen delivery. It is also used to reduce the risk of hospitalization and death due to PAH.
Veletri is manufactured by Actelion Pharmaceuticals, a subsidiary of Johnson & Johnson. It is approved for use in the United States, Europe, and other countries. Other companies that produce cardiovascular drugs include GlaxoSmithKline, Novartis, and Pfizer. Show Less Read more